ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...
4don MSN
After 7 years on dialysis, his life was transformed by the world's first ever bladder transplant
Since then, Dr. Nassiri and Inderbir Gill, MD, chair of the department of urology at USC Keck School of Medicine, had ...
Scientists uncovered how childhood BK virus infections may set off cancer-causing mutations decades later: by activating a ...
A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society of Urologic Oncology 2025 Annual Meeting (SUO) ...
Cretostimogene demonstrated HG-EFS at 3- 6- and 9-months of 95.7%, 84.6% and 80.4%, respectively, in HR BCG UR Ta/T1 Disease in BOND-003 Cohort ...
MOBILE, Ala. (WKRG) — November is Bladder Health Awareness Month, and Infirmary Health’s Laurie Repoll, PT joined WKRG News 5 on Take 5 to raise awareness on bladder health. In the video above, Repoll ...
The U.S. Food and Drug Administration (FDA) on Friday approved injectable and intravenous versions of Merck’s (MRK) blockbuster anti-PD-1 therapy Keytruda for bladder cancer as part of a combination ...
As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the positive readout of Keynote-905 study—also known as EV-303—terms like ...
Keytruda and Padcev combination shows improved event-free and overall survival in muscle invasive bladder cancer patients ineligible for cisplatin. The KEYNOTE-905/EV-303 trial demonstrated ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph in combination with enfortumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback